Skip to main content
SpringerLink
Log in
Book cover

Inflammatory Bowel Disease pp 151–164Cite as

State-of-the-Art Management of the Pediatric IBD Patient

  • Chapter
  • First Online:

  • 1750 Accesses

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Approximately 20% of inflammatory bowel disease (IBD) cases present in the pediatric or adolescent age group. Genetics and specific serum immune markers may identify children with more aggressive Crohn’s disease. Both upper and lower endoscopies with biopsies should be performed in pediatric patients suspected of having IBD. Earlier appropriate use of thiopurines, and subsequently biologics, should be considered in patients sick enough to require corticosteroids. Growth failure and defective bone mass accrual are risks specific for this population that are multifactorial in nature and must be correctly identified, quantitated, and treated, when possible. Adherence to prescribed medication regimens is low in the pediatric and adolescent population, especially among children with dysfunctional families or with poor coping strategies.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Auvin S, Molinie F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988–1999). J Pediatr Gastroenterol Nutr. 2005;41:49–55.

    Article  PubMed  Google Scholar 

  2. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Wisconsin Pediatric Inflammatory Bowel Disease Alliance. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525–31.

    Article  Google Scholar 

  3. Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn’s disease. Immunol Rev. 2005;206:277–95.

    Article  PubMed  CAS  Google Scholar 

  4. Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, et al. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn’s disease. Inflamm Bowel Dis. 2005;11:631–8.

    Article  PubMed  Google Scholar 

  5. Weiss B, Shamir R, Bujanover Y, Waterman M, Hartman C, Fradkin A, et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn’s disease. J Pediatr. 2004;145:208–12.

    Article  PubMed  CAS  Google Scholar 

  6. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nature Genetics. 2009;41:1335–40.

    Google Scholar 

  7. Kugathasan S, Collins N, Maresso K, Hoffmann RG, Stephens M, Werlin SL, et al. CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2:1003–9.

    Article  PubMed  CAS  Google Scholar 

  8. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115(4):822–9.

    Article  PubMed  CAS  Google Scholar 

  9. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, et al. Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. BMJ. 1988;297:1105–6.

    Google Scholar 

  10. Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, et al. Colonic ­bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000;68:1542–8.

    Article  PubMed  CAS  Google Scholar 

  11. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease. Gastroenterology. 2005;128:2020–8.

    Article  PubMed  CAS  Google Scholar 

  12. Dubinsky MC, Lin YC, Dutridge D, Picornell Y, Landers CJ, Farrior S, et al. Serum immune responses predict rapid disease progression among children with Crohn’s disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360–7.

    Article  PubMed  Google Scholar 

  13. Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn’s disease patients. Am J Gastroenterol. 2006;101:645–52.

    Article  PubMed  Google Scholar 

  14. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Inflammatory bowel disease in children and adolescents: recommendations for diagnosis – the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.

    Article  Google Scholar 

  15. Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2004;39:257–61.

    Article  PubMed  CAS  Google Scholar 

  16. Batres LA, Maller ES, Ruchelli E, Mahboubi S, Baldassano RN. Terminal ileum intubation in pediatric colonoscopy and diagnostic value of conventional small bowel contrast radiography in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35:320–3.

    Article  PubMed  Google Scholar 

  17. Darbari A, Sena L, Argani P, Oliva-Hemker JM, Thompson R, Cuffari C. Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm Bowel Dis. 2004;10:67–72.

    Article  PubMed  Google Scholar 

  18. Jamieson DH, Shipman PJ, Israel DM, Jacobson K. Comparison of multidetector CT and barium studies of the small bowel: inflammatory bowel disease in children. AJR Am J Roentgenol. 2003;180:1211–6.

    Article  PubMed  Google Scholar 

  19. Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:733–8.

    Article  PubMed  Google Scholar 

  20. Grahnquist L, Chapman SC, Hvidsten S, Murphy MS. Evaluation of 99mTc-HMPAO leukocyte scintigraphy in the investigation of pediatric inflammatory bowel disease. J Pediatr. 2003;143:48–53.

    Article  PubMed  Google Scholar 

  21. Guilhon de Araujo Sant’Anna AM, Dubois J, Miron MC, Seidman EG. Wireless capsule endoscopy for obscure small-bowel disorders: final results of the first pediatric controlled trial. Clin Gastroenterol Hepatol. 2005;3:264–70.

    Article  PubMed  Google Scholar 

  22. Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;33:14–22.

    Article  PubMed  CAS  Google Scholar 

  23. Dubinsky MC, Johanson JF, Seidman EG, Ofman JJ. Suspected inflammatory bowel disease – the clinical and economic impact of competing diagnostic strategies. Am J Gastroenterol. 2002;97:2333–42.

    PubMed  Google Scholar 

  24. Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, et al. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004;28:190–7.

    Article  PubMed  Google Scholar 

  25. Rajwal SR, Puntis JW, McClean P, Davison SM, Newell SJ, Sugarman I, et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr. 2004;38:66–9.

    Article  PubMed  Google Scholar 

  26. Fleshner P, Vasiliauskas E, Dubinsky M, Mei L, Landers C, Ippolitti A, et al. Both ­preoperative pANCA and CBir1 flagellin expression in ulcerative colitis (UC) patients influence pouchitis development after ileal pouch anal anastomosis. Gastroenterology. 2006;130:A25.

    Google Scholar 

  27. Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006;4:744–53.

    Article  PubMed  Google Scholar 

  28. D’Haens GR, Hommes D, Baert F, de Vos M, Caenepeel F, van Assche G, et al. A combined regimen of infliximab and azathioprine induces better endoscopic healing than classic step UP therapy in newly diagnosed Crohn’s disease. Gastroenterology. 2006;130:A110.

    Google Scholar 

  29. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn’s disease. Gastroenterology. 2000;119:895–902.

    Article  PubMed  CAS  Google Scholar 

  30. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705–13.

    Article  PubMed  CAS  Google Scholar 

  31. Hyams J, Crandall W, Kugathasan S, Griffiths AM, Olsen A, Johanns J, et al. Maintenance therapy with infliximab every 8 wk is superior to every 12 weeks in maintaining response and remission in pediatric patients with moderately to severely active Crohn’s disease. Gastroenterology. 2006;130:A12.

    Google Scholar 

  32. Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clinical Gastroenterology & Hepatology. 2011;9:36–41.e1.

    Google Scholar 

  33. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. ACCENT I Study Group. Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet. 2002;359(9317):1541–9.

    Article  Google Scholar 

  34. Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41(9):1552–63.

    Article  PubMed  CAS  Google Scholar 

  35. Stephens MC, Baldassano RN, York A, Widemann B, Pitney AC, Jayaprakash N, et al. The bioavailability of oral methotrexate in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2005;40:445–9.

    Article  PubMed  CAS  Google Scholar 

  36. Jacobstein DA, Mamula P, Markowitz JE, Leonard M, Baldassano RN. Predictors of immunomodulator use as early therapy in pediatric Crohn’s disease. J Clin Gastroenterol. 2006;40:145–8.

    Article  PubMed  CAS  Google Scholar 

  37. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn’s disease. Gastroenterology. 1988;95:1523–7.

    PubMed  CAS  Google Scholar 

  38. Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, et al. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A. 2005;102:13260–5.

    Article  PubMed  CAS  Google Scholar 

  39. Calenda KA, Schornagel IL, Sadeghi-Nejad A, Grand RJ. Effect of recombinant growth hormone treatment on children with Crohn’s disease and short stature: a pilot study. Inflamm Bowel Dis. 2005;11:435–41.

    Article  PubMed  Google Scholar 

  40. IBD and Skeletal Health. Children are not small adults! Inflamm Bowel Dis. 2005;11:1020–3.

    Article  Google Scholar 

  41. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res. 2001;16:1658–64.

    Article  PubMed  CAS  Google Scholar 

  42. Bachrach LK. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin North Am. 2005;34:521–35.

    Article  PubMed  Google Scholar 

  43. Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, et al. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr. 2004;38:276–80.

    Article  PubMed  CAS  Google Scholar 

  44. Griffiths AM, Nicholas D, Smith C, et al. Development of a quality-of life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr. 1999;28:S46–52.

    Article  PubMed  CAS  Google Scholar 

  45. Otley A, Smith C, Nicholas D, et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35:557–63.

    Article  PubMed  Google Scholar 

  46. Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, et al.; for the Pediatric IBD Collaborative Research Group. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:684–91.

    Article  Google Scholar 

  47. Loonen HJ, Derkx BHF, Koopman HM, Heymans HSA. Are parents able to rate the symptoms and quality of life of their offspring with IBD? Inflamm Bowel Dis. 2002;8:270–6.

    Article  PubMed  Google Scholar 

  48. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol. 2005;100(6):1386–92.

    Article  PubMed  Google Scholar 

  49. Rapoff MA. Adherence to pediatric medical regimens. New York: Kluwer Academic; 1999.

    Google Scholar 

  50. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:1006–12.

    Article  PubMed  Google Scholar 

  51. Hait E, Arnold JH, Fishman LN. Educate, communicate, anticipate – practical recommendations for transitioning adolescents with IBD to adult health car. Inflamm Bowel Dis. 2006;12:70–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric IBD Center, Cedars-Sinai Medical Center, David Geffen School of Medicine, UCLA, 8700 Beverly Boulevard, Suite 1165W, Los Angeles, CA, 90048, USA

    Marla Dubinsky

Authors
  1. Marla Dubinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marla Dubinsky .

Editor information

Editors and Affiliations

  1. MC 4076, Sect. Of GE, Hepatol. & Nutr., Department of Medicine, University of Chicago Medical Center, S. Maryland Ave. 5841, Chicago, 60637, Illinois, USA

    Russell D. Cohen

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dubinsky, M. (2011). State-of-the-Art Management of the Pediatric IBD Patient. In: Cohen, R. (eds) Inflammatory Bowel Disease. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-433-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-433-3_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-432-6

  • Online ISBN: 978-1-60327-433-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation